NewsBenzingaInMed Pharmaceuticals、第1四半期EPSは(0.36ドル)で、前年同期の(0.46ドル)から改善 InMed Pharmaceuticals、第1四半期EPSは(0.36ドル)で、前年同期の(0.46ドル)から改善 Benzinga 2026.11.03 14:03 (GMT+0) Open on Benzinga Other news Freedom Broker Maintains Buy on XPeng, Lowers Price Target to $20 Plug Power Shares Slide Toward 52-Week Low Despite New 280-MW Texas Deal Nvidia Vs. Anthropic: Can the AI IPO Challenge Nvidia’s Dominance Across ETFs? Freedom Broker Maintains Buy on Allot, Lowers Price Target to $12.7 Freedom Broker Upgrades M-Tron Industries to Buy, Lowers Price Target to $84 As decision model use skyrockets, is customization is the next frontier?